Showing results (11-20 of 71,625) with videos related to
Sort By:
Pageof 7,163
Clinical and Experimental Rheumatology|February 19, 2004
The histopathology of early synovitisC A Hitchon, H S el-GabalawyCurrent Opinion in Rheumatology|May 3, 2011
Infection and rheumatoid arthritis: still an open questionCarol A Hitchon, Hani S El-GabalawyPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 13, 2002
Three-dimensional solutions of the Boltzmann equation: heat transport at long mean free pathsA J Christlieb, W N G HitchonCurrent Opinion in Rheumatology|July 16, 2002
Immune features of seronegative and seropositive arthritis in early synovitis studiesCarol A Hitchon, Hani S El-GabalawyCase Reports in Medicine|July 16, 2014
Acute Sciatic Neuritis following Lumbar LaminectomyFoad Elahi, Patrick Hitchon, Chandan G ReddyProstaglandins|November 1, 1980
Aryl sulfatase inactivation of slow reacting substance. Evidence for proteolysis as a major mechanism when ordinary commercial preparations of the enzyme are usedC W Parker, D A Koch, M M Huber, et al.Evolution; International Journal of Organic Evolution|May 21, 2009
When to go: optimization of host switching in parasites with complex life cyclesKatrin Hammerschmidt, Kamilla Koch, Manfred Milinski, et al.Mediators of Inflammation|June 3, 2017
Buprenorphine Alters Inflammatory and Oxidative Stress Molecular Markers in ArthritisMahadevappa Hemshekhar, Vidyanand Anaparti, Carol Hitchon, et al.Applied Neurophysiology|January 1, 1985
Accuracy of CT scans in identifying tumor tissueP W Hitchon, R L Schelper, T BarloonJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1980
Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathwayS F Falkenhein, H MacDonald, M M Huber, et al.Pageof 7,163